Distribution of Silent Cerebral Infarcts in Adults with Sickle Cell Disease
Neurol 102:e209247, Jones,R.S.,et al, 2024
A Case of Acute Akinetic Mutism and Encephalopathy
Neurol 99:761-766, Jain, V.,et al, 2022
Catastrophic Cerebral Fat Embolism Syndrome Lacks Hyperacute MRI Findings
Neurol: Clin Pract 6:e962-e964, Gusler, M.T.,et al, 2021
Fat Embolism Syndrome in Sickle Cell Disease
J Clin Med 9:1-12, Tsitsikas, D.A.,et al, 2020
Cerebral Fat Embolism Syndrome in Sickle Cell Disease Without Evidence of Shunt
eNeurologicSci 14:19-20, Nathan, C.L.,et al, 2018
A Case of Fulminant Encephalopathy in a 69-year-old Woman
Neurol 89:e109-e114, Lamotte, G. and Williams, C, 2017
Fat Embolism Syndrome Secondary to Bone Marrow Necrosis in Patients with Hemoglobinopathies
SMJ 109:549-553, Gangaraju, R.,et al, 2016
Cerebral Microhaemorrhages Secondary to Fat Embolus Syndrome in Sickle Cell Disease
Postgrad Med Jour 91:55-56, Alobeidi, F.,et al, 2015
Controlled Trial of Transfusions for Silent Cerebral Infarcts in Sickle Cell Anemia
NEJM 371:699-710, DeBaun, M.R.,et al, 2014
Bone Marrow Necrosis and Fat Embolism Syndrome in Sickle Cell Disease: Increased Susceptibility of Patients with Non-SS genotypes and a Possible Association with Human Parvovirus B19 Infection
Blood Rev 28:23-30, Tsitsikas, D.A.,et al, 2014
Cerebral Fat Embolism Syndrome in Sickle Cell Anaemia/�-Thalassemia: Importance of Susceptibility-weighted MRI
Clin Radiol 67:1023-1026, Mossa-Basha, M.,et al, 2012
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:227-276, Furie,K.L.,et al, 2011
Management of Stroke in Infants and Children: A Scientific Statement From a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young
Stroke 39:2644-2691, Roach,E.S.,et al., 2008
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
Stroke 37:577-617, Sacco,R.L.,et al, 2006
Brain Injury in Children with Sickle Cell Disease: Prevalence and Etiology
Ann Neurol 54:564-572,559, Steen,R.G.,et al, 2003
Stroke Prevention and Treatment in Sickle Cell Disease
Arch Neurol 58:565-568, Adams,R.J., 2001
Discontinuation of Long-Term Transfusion Therapy in Patients with Sickle Cell Disease & Stroke
J Pediatr 131:757-760, Rana,S.,et al, 1997
Risk of Recurrent Stroke in Patients with Sickle Cell Disease Treated with Erythrocyte Transfusions
J Pediatr 126:896-899, Pegelow,C.H.,et al, 1995
Stroke in a Cohort of Patients with Homozygous Sickle Cell Disease
J Pediatr 120:360-366, Balkaran,B.,et al, 1992
High Risk of Recurrent Stroke after Discont of 5 to 12 Yrs of Transfusions in Sickle Cell Disease
J Pediatr 118:377-379, Wang,W.C.,et al, 1991
Mendelian Etiologies of Stroke
Ann Neurol 22:175-192, Natowicz,M.&Kelley,R.I., 1987
Sickle Cell Anemia & Central Nervous System Infarction:A Neuropathologic Study
Ann Neurol 20:684-690, Rothman,S.M.,et al, 1986
The Natural History of Stroke in Sickle Cell Disease
Am J Med 65:461-471, Powars,D.,et al, 1978
The Nervous System in Sickle Cell Disease
Afr J Med Sci 1:33, Adelove,A.,et al, 1970